Collaborating Authors

What's next for augmented reality in spine surgery?


Augmented reality in spine surgery is taking off, and its growth could be exponential in the near future. With more and more places adopting the technology, many surgeons have a positive outlook for the technology. It's the first AR system driven by artificial intelligence, using machine-learning-based guidance and automated surgical planning. In December, Royal Philips expanded its ClarifyEye AR spine system in Spain and Oman. In February, Neo Medical raised $20.6 million in funding, which will support the product's U.S. launch.

3 unexpected ways you'll soon find AR/VR in healthcare


Medical technology is changing faster than it ever has before, and it's now clear Augmented Reality and Virtual Reality will play a role in the standard care we receive. The promise of the technologies is astounding. It won't be long before a nurse can read your diagnostics at a glance thanks to an AR headset. As research into mindfulness and the brain's ameliorative power advances, new VR applications will offer anesthesia-intolerant patients opportunities for pain-free surgeries. But what usually gets lost in conversations about the promise of these technologies is the current generation of mixed reality applications that are in use in healthcare today.

IoT weekly round-up: Thursday 21st September 2017


This week, the connected world brings artificial intelligence and augmented reality to medicine, robots have a go at music making and Matternet's autonomous drones ditch their human minders and successfully refuel themselves. Autonomous drone delivery service Matternet has developed an automated base station where drones can refuel and swap payloads by themselves.

Medtronic Completes Acquisition of Medicrea


Acquisition Expands Medtronic's Artificial Intelligence and Data Capabilities, Becoming the First Company to Offer an Integrated Spine Solution Including AI-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery DUBLIN, Nov. 16, 2020 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has completed its friendly tender offer for France-based Medicrea International (Euronext Growth Paris: FR0004178572 – ALMED Medicrea; OTCQX Best Market – MRNTF), a pioneer in the transformation of spinal surgery through artificial intelligence (AI), predictive modeling and patient specific implants. On July 15, 2020, the parties announced a friendly voluntary all-cash tender offer at the price of €7.00 per Medicrea share. As a result of completion of the tender offer, Medtronic currently owns in excess of 90% of Medicrea's share capital and voting rights and will shortly request the implementation of a squeeze-out procedure under French law, which will result in Medicrea becoming a wholly-owned subsidiary of Medtronic. This is Medtronic's seventh acquisition completed in 2020 and furthers Medtronic's strategic expansion into AI, machine learning and predictive analytics. Medicrea's product portfolio consists of 30 510(k) cleared or CE Marked implant technologies, utilized in spinal surgeries for adult deformity, pediatric deformity and degenerative disease.

Surgalign receives FDA clearance for AI-driven HOLO Portal system for spine surgery - Spinal News International


Surgalign Holdings has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its HOLO Portal surgical guidance system for use within lumbar spine procedures. According to Surgalign, the HOLO Portal system is the world's first artificial intelligence (AI)-driven augmented reality (AR) guidance system for spine and the first clinical application of Surgalign's HOLO AI digital health platform. Terry Rich, president and chief executive officer of Surgalign, said: "Receiving the initial clearance for the HOLO Portal system is a significant milestone and represents a critical step toward building the foundation of the digital surgery of the future. This system is designed to improve patient outcomes by delivering intelligent solutions to our customers, and we believe it is truly revolutionary. "With clearance in hand for our guidance application, our near-term focus is getting the platform into the hands of surgeons as we work towards a market release.